The European Patent Office (EPO) has published patent application EP3988565A1, detailing advancements in T Cell Receptors. The publication, dated March 11, 2026, lists USWM CT, LLC as the applicant and Nicholas Tribble, William Lawrance, and Eleanor Bagg as inventors. The application's International Patent Classification (IPC) includes codes related to peptides, therapeutic uses, and cell culture, indicating a focus on novel biological treatments.

This publication represents a new patent application and does not impose immediate compliance obligations on regulated entities. However, it is relevant for companies operating in the pharmaceutical and biotechnology sectors, particularly those involved in the development of immunotherapies or cell-based treatments. Legal and R&D departments should monitor the progress of this patent application, as its eventual grant could impact intellectual property landscapes and future product development strategies in the field of T Cell Receptors.